Data as of Oct 28, 2026.
ARKG vs GDXJ: Holdings Overlap & Returns
Over the year to Oct 28, 2026, ARKG returned +80.0% to GDXJ's +14.8%; 0% of their weight is in the same names.
askIQ about this page
askIQ about ARKG and GDXJ
Net assets on Oct 27, 2026: $2.2bn for ARK Genomic Revolution ETF and $7.6bn for VanEck Junior Gold Miners ETF.
4% of ARKG's weight is in S&P 500 companies and 96% is outside the index. Holdings as of Oct 27, 2026.
0% of GDXJ's weight is in S&P 500 companies and 100% is outside the index. Holdings as of Oct 22, 2026.
Pair scorecard
GDXJ costs 0.23 points a year less; their one-year returns differ by 65.2 points; GDXJ is 3.5 times larger.
Points (pts) are percentage points.
| Measure | ARKG | GDXJ |
|---|---|---|
| Return | ||
| Total return, 1 year | +80.0% | +14.8% |
| Drawdown | ||
| Below its all-time high | 50.9%, high on Jan 20, 2021 | 33.1%, high on Feb 27, 2026 |
| Against its benchmark | ||
| What it tracks | Genomics and gene editing | Gold miners |
| Its benchmark, total return, 1 year | +13.4% | |
| Against its benchmark, 1 year | ahead by 1.4 pts | |
| Cost and size | ||
| Expense ratio | 0.75% | 0.52% |
| Net assets, as of Oct 27, 2026 | $2.2bn | $7.6bn |
| Active share vs the S&P 500 | 98% | 100% |
| Holdings | ||
| Holdings in common | 0% | |
Holdings in common uses holdings dated Oct 27, 2026. Method
Risk and return
Nov 7, 2014 to Oct 23, 2026 · 624 weekly returnsGDXJ returned more: +352.2% to +161.9%. ARKG swung slightly less: 39.8% to 42.2%. GDXJ fell less at its worst: −54.1% to −82.9%.
Full scorecard
9 measures, with how each is measured Open ↓
| Measure | ARKG | GDXJ | Edge | How it is measured |
|---|---|---|---|---|
| Return | ||||
| Total return | +161.9% | +352.2% | GDXJ | Price change plus distributions, reinvested. |
| Annualized | +8.4% | +13.4% | GDXJ | Total return as a yearly rate. |
| Price return | +145.1% | +281.5% | GDXJ | Price change alone, distributions left out. |
| Risk | ||||
| Volatility | 39.8% | 42.2% | ARKG (slight) | Spread of weekly returns, annualized. Lower is steadier. |
| Downside deviation | 26.2% | 28.9% | ARKG (slight) | Like volatility, counting only weeks below the Treasury bill rate. |
| Max drawdown | −82.9% | −54.1% | GDXJ | Deepest fall from a high to the low after it. |
| Risk-adjusted | ||||
| Sharpe | 0.35 | 0.47 | GDXJ | Return above Treasury bills per unit of volatility. |
| Sortino | 0.53 | 0.68 | GDXJ | Return above Treasury bills per unit of downside deviation. |
| Calmar | 0.10 | 0.25 | GDXJ | Annualized return divided by the max drawdown. |
Computed by ETFIQ from Tiingo daily prices and ETFIQ's distribution records, 624 weekly returns. Cash rate: the 13-week Treasury bill.
What they share
By the books each fund has filed, ARKG and GDXJ hold 0% of their money in the same securities at the same weight. Holdings dated Oct 27, 2026.
half
0% in common
Only in one fund ↓
Window by window
| Total return | vs its benchmark | |||
|---|---|---|---|---|
| Window | ARKG | GDXJ | ARKG | GDXJ |
| 3 months | +46.2% | +9.9% | not measured | +5.5 pts vs ACWI |
| 6 months | +92.1% | −8.0% | not measured | −15.4 pts vs ACWI |
| 1 year | +80.0% | +14.8% | not measured | +1.4 pts vs ACWI |
| 3 years | +146.5% | +220.2% | not measured | +131.3 pts vs ACWI |
| Since launchNot the same days: ARKG Oct 2014 · GDXJ Nov 2009 | +191.5% | +44.9% | not measured | not measured |
Side by side
As of Oct 28, 2026. Source: ETFIQ.
0% of the two portfolios are the same securities at the same weight.
ARKG and GDXJ are built for the same job. How do they differ in cost, holdings and results?
- Theme. ARKG covers Genomics and gene editing and GDXJ covers Gold miners.
- Concentration. The top ten holdings are 58.3% of ARKG and 40.8% of GDXJ, a gap of 17.5 points.
- What each follows. ARKG follows Genomics and gene editing and GDXJ follows Gold miners.
Data as of Oct 28, 2026.
The two-page PDF for this pair is coming. Save the comparison to follow its changes. Free. It needs an email sign-in, once.
ARKG
By weight, 4% of ARKG's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 98%. The top ten holdings are 58% of the fund across 35 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +80.0% with distributions reinvested. It sits 50.9% below its all-time high of Jan 20, 2021.
GDXJ
By weight, 0% of GDXJ's portfolio is stocks that are also in the S&P 500; its active share against the S&P 500 is 100%. The top ten holdings are 41% of the fund across 156 positions, as published by its issuer for Oct 27, 2026. Over the year to Oct 28, 2026 the fund returned +14.8% with distributions reinvested against +13.4% for its benchmark, the MSCI ACWI Index, so a holder was ahead by 1.4 pts. It sits 33.1% below its all-time high of Feb 27, 2026.
Questions people ask
- Do ARKG and GDXJ hold the same stocks?
- By their latest filings, 0% of their books are the same securities at the same weight. Overlap is the sum of the smaller weight of every security they share.
Links are sources, not endorsements. A comparison is not a recommendation.
How this is computed
Overlap adds up the smaller of the two weights for each security both funds hold.
Every number is an ETFIQ calculation with distributions reinvested.
Cite this pageCitation, APA and Markdown
ETFIQ, ARKG against GDXJ, data as of Oct 28, 2026. https://etfiq.com/compare/themes/arkg-vs-gdxj
ETFIQ. (Oct 28, 2026). ARKG against GDXJ. Retrieved from https://etfiq.com/compare/themes/arkg-vs-gdxj
[ARKG against GDXJ (ETFIQ, Oct 28, 2026)](https://etfiq.com/compare/themes/arkg-vs-gdxj)
Free to use with attribution for data ETFIQ computes; issuer data stays under its owner's terms.